Season's Savings | ₹5/mo for 3 months

₹199/month after first 3 months. Renews automatically. Terms apply.
Blunt Business cover art

Blunt Business

Blunt Business

Written by: Cannabis Radio
Listen for free

About this listen

Dispensing Cannabis business knowledge beyond a million square feet of cultivation space. Blunt Business navigates the challenges and opportunities of one of the most profitable industries on earth. Join us each episode to hear our weekly round tables and interviews with industry professionals.

Copyright Cannabis Radio
Economics Management Management & Leadership
Episodes
  • Do Utah and the UK Prove Clinical Oversight Is the Future of Medical Cannabis
    Nov 18 2026

    As daily cannabis use climbs to roughly 1.2 million people in Great Britain (Forbes), retail pharmacy giant Boots is launching its SureLeaf online prescription service across roughly 1,800 UK locations to offer affordable medical cannabis flower and oil starting at £40—a mainstream breakthrough modeled directly on clinical pharmacy integration (MJBizDaily; The Telegraph). This rollout mirrors the clinical blueprint pioneered in Utah, where state law replaces traditional retail "budtenders" with licensed Pharmacy Medical Providers (PMPs) who review patient medical histories, screen for CYP-mediated drug interactions, and guide individualized dose titration (Pharmacy Times; Cannabis Industry Journal). Together, Utah's established framework and the UK's high-street expansion validate a crucial lesson underscored by pharmacy policy experts (Pharmacy Times): embedding licensed pharmacists into regulated cannabis distribution—rather than sidelining them as Canada did (Pharmacy Times)—legitimizes the plant as a safe, standardized therapeutic, protects vulnerable patients, and unlocks sustainable mainstream market growth.



    Advertising Inquiries: https://redcircle.com/brands

    Privacy & Opt-Out: https://redcircle.com/privacy
    Show More Show Less
    10 mins
  • Abstrax Revolutionizes Terpenes, Hops, and Cannabis Innovation
    Nov 11 2026

    Blunt Business welcomes back Kevin Koby, CEO and co-founder of Abstrax Tech. Returning to the show five and a half years after his first appearance, Koby discusses his transition from Chief Scientific Officer to CEO and highlights how Abstrax Tech has evolved from a terpene distributor to an industry leader in aroma chemistry and analytical research.



    Advertising Inquiries: https://redcircle.com/brands

    Privacy & Opt-Out: https://redcircle.com/privacy
    Show More Show Less
    37 mins
  • DEA Rescheduling and Form 225 Compliance Overview
    Nov 4 2026

    Blunt Business speaks with Jonathan Wachs regarding the DEA’s proposed Schedule 3 rescheduling process, the launching of the Form 225 registration portal for medical cannabis operators, and the regulatory and compliance challenges facing businesses in dual-use markets.

    The Drug Enforcement Administration (DEA) has launched its Schedule 3 registration portal using Form 225 for medical cannabis manufacturers, distributors, and analytical laboratories. Applying through the system involves substantial non-refundable annual registration fees, set at $3,699 for manufacturers, $1,850 for distributors, and $296 for analytical labs.

    Given the complexity of the disclosures required on Form 225, Wachs advises operators to retain legal counsel to ensure accurate filings and navigate potential legal exposures.




    Advertising Inquiries: https://redcircle.com/brands

    Privacy & Opt-Out: https://redcircle.com/privacy
    Show More Show Less
    37 mins
adbl_web_anon_alc_button_suppression_t1
No reviews yet